Literature DB >> 6119321

Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.

S Marcovitz, C G Goodyer, H Guyda, R J Gardiner, J Hardy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6119321     DOI： 10.1210/jcem-54-1-6

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  12 in total

Review 1.  Neuroendocrine regulation of human growth hormone secretion. Diagnostic and clinical applications.

Authors:  G Delitala; P Tomasi; R Virdis
Journal:  J Endocrinol Invest       Date:  1988-06       Impact factor: 4.256

2.  Inversely related evolution of growth hormone and prolactin secretions in long-term tissue cultures of human pituitary adenomas from acromegalic patients.

Authors:  B Loras; J Trouillas; Y Li; A Durand; C Girod; J Bertrand
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

3.  Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients.

Authors:  F Duval; M C Mokrani; J P Macher; M A Crocq; J O Castro; P Bailey; X Lataste
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Interaction of L-dopa and GHRH on GH secretion in normal men.

Authors:  J Alba-Roth; C von Creytz; G Mehltretter; J Schopohl; O A Müller; K von Werder
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

5.  Chronic hyperprolactinemia and plasma lipids in women.

Authors:  H M Heshmati; G Turpin; J L de Gennes
Journal:  Klin Wochenschr       Date:  1987-06-01

6.  Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.

Authors:  M O Thorner; R L Perryman; M J Cronin; A D Rogol; M Draznin; A Johanson; W Vale; E Horvath; K Kovacs
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

7.  The effect of Yohimbine, an alpha2 adrenergic receptor antagonist, on the growth hormone response to apomorphine in normal subjects.

Authors:  S Lal; J X Thavundayil; B Krishnan; N P Nair; G Schwartz; H Guyda
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

8.  Stereospecificity of the dopamine receptor mediating the growth hormone response to apomorphine in man. Short communication.

Authors:  S Lal; N P Nair; J X Thavundayil; V Tawar; R Quirion; H Guyda
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 9.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

10.  The effects of growth hormone-releasing factor (GRF) and dopamine on growth hormone (GH) secretion in acromegaly.

Authors:  M Giusti; A Lomeo; G Mazzocchi; D Mignone; P Sessarego; M Monachesi; G Giordano
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.